Trial intelligence / Profile preview

MWN109 in Non-Diabetic Participants With Overweight or Obesity

NCT07791537Phase 2Active, not recruiting

Sponsor
Shanghai Minwei Biotechnology Co., Ltd.
Start
Dec 2025
Primary completion
Oct 2026
Countries
1
01

Overview

A Phase 2 trial of MWN109 in Overweight, obesity, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Dec 2025; status: active, not recruiting.

02

Drugs

MWN109
03

Conditions

Overweightobesity

Beyond the preview

Go deeper on NCT07791537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07791537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call